Literature DB >> 8888739

Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis.

R M Egeler1, R Shapiro, B Loechelt, A Filipovich.   

Abstract

PURPOSE: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome characterized by fever, hepatosplenomegaly, pancytopenia, and infiltration of vital organs by non-Langerhans histiocytes and is rapidly fatal without early diagnosis and institution of therapy. Immune dysregulation is thought to be responsible for the disease. PATIENTS AND METHODS: Extensive immune evaluation was performed on 13 consecutive patients diagnosed with HLH over a 4-year period to characterize existing immunologic abnormalities in order to improve early diagnosis. Evaluation included quantitative immunoglobulins, immunophenotyping, mitogen-induced lymphoproliferation, natural killer (NK) cell function, and cytotoxic T cell lymphocytolysis (CTL).
RESULTS: Immunoglobulin levels showed no consistent abnormality. Immunophenotyping showed an absolute decrease in number of B cells but normal numbers and proportional distribution of T cell subsets and NK cells. Most patients demonstrated decreased proliferative responses to mitogens (10/13) and severely decreased to absent T cell cytotoxicity (11/12) and NK cytotoxic function (13/13).
CONCLUSIONS: Our results show that while humoral immunity is essentially intact, cellular immune function is significantly impaired in the vast majority of patients with HLH. The coincident finding of profoundly decreased T cell cytotoxicity along with absent NK cytotoxicity suggests that patients with active HLH may have global cytotoxic dysfunction. Since the majority of our patients were studied prior to starting therapy, we feel that these findings reflect the pathophysiologic process and are not therapy related. Unclear from the present work is whether these findings represent primary or secondary dysfunction. We conclude from these studies that profoundly decreased CTL function and absence of NK cell function are characteristic immunologic features of HLH and may serve as additional laboratory data, in conjunction with currently proposed diagnostic guidelines, to support a diagnosis of HLH.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8888739     DOI: 10.1097/00043426-199611000-00002

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  27 in total

1.  Functional assessment of perforin C2 domain mutations illustrates the critical role for calcium-dependent lipid binding in perforin cytotoxic function.

Authors:  Ramon Urrea Moreno; Juana Gil; Carmen Rodriguez-Sainz; Elena Cela; Victor LaFay; Brian Oloizia; Andrew B Herr; Janos Sumegi; Michael B Jordan; Kimberly A Risma
Journal:  Blood       Date:  2008-10-16       Impact factor: 22.113

2.  Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH.

Authors:  Kejian Zhang; Michael B Jordan; Rebecca A Marsh; Judith A Johnson; Diane Kissell; Jarek Meller; Joyce Villanueva; Kimberly A Risma; Qian Wei; Peter S Klein; Alexandra H Filipovich
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

Review 3.  How I treat hemophagocytic lymphohistiocytosis.

Authors:  Michael B Jordan; Carl E Allen; Sheila Weitzman; Alexandra H Filipovich; Kenneth L McClain
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

4.  Impaired immune function in children with Fanconi anaemia.

Authors:  Kasiani C Myers; Jack J Bleesing; Stella M Davies; Xue Zhang; Lisa J Martin; Robin Mueller; Richard E Harris; Alexandra H Filipovich; Melinda B Kovacic; Susanne I Wells; Parinda A Mehta
Journal:  Br J Haematol       Date:  2011-05-04       Impact factor: 6.998

5.  Spectrum of perforin gene mutations in familial hemophagocytic lymphohistiocytosis.

Authors:  K Göransdotter Ericson; B Fadeel; S Nilsson-Ardnor; C Söderhäll; A Samuelsson; G Janka; M Schneider; A Gürgey; N Yalman; T Révész; R Egeler; K Jahnukainen; I Storm-Mathiesen; A Haraldsson ; J Poole; G de Saint Basile; M Nordenskjöld; J Henter
Journal:  Am J Hum Genet       Date:  2001-02-06       Impact factor: 11.025

6.  Pediatric hemophagocytic syndromes: a diagnostic and therapeutic challenge.

Authors:  Nada Jabado; Christine McCusker; Genevieve de Saint Basile
Journal:  Allergy Asthma Clin Immunol       Date:  2005-12-15       Impact factor: 3.406

7.  X-linked severe combined immunodeficiency due to a novel mutation complicated with hemophagocytic lymphohistiocytosis and presented with invagination: A case report.

Authors:  Turkan Patiroglu; H Haluk Akar; Mirjam van den Burg; Ekrem Unal; Basak N Akyildiz; Nazan U Tekerek; Ebru Yilmaz
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-09-11

8.  Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis.

Authors:  Kejian Zhang; Shanmuganathan Chandrakasan; Heather Chapman; C Alexander Valencia; Ammar Husami; Diane Kissell; Judith A Johnson; Alexandra H Filipovich
Journal:  Blood       Date:  2014-06-10       Impact factor: 22.113

9.  Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping.

Authors:  M Ohadi; M R Lalloz; P Sham; J Zhao; A M Dearlove; C Shiach; S Kinsey; M Rhodes; D M Layton
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

10.  Genetic dissection of NK cell responses.

Authors:  Peter Moussa; Jennifer Marton; Silvia M Vidal; Nassima Fodil-Cornu
Journal:  Front Immunol       Date:  2013-01-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.